Enanta Pharmaceuticals (ENTA) Operating Leases (2019 - 2026)
Enanta Pharmaceuticals' Operating Leases came in at $51.75 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 7.0% from $55.66 million a year earlier and down 1.9% from the prior quarter.
Enanta Pharmaceuticals (ENTA) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals' Operating Leases was $54.76 million, up 1.5% from FY2024.
- Operating Leases carries a five-year compound annual growth rate of 70.2% (FY2020 to FY2025).
- Going back by fiscal year, Operating Leases was $53.94 million in FY2024 (+154.0%), $21.24 million in FY2023 (-5.1%), $22.37 million in FY2022 and $1.13 million in FY2021 (-70.7%).
- The fiscal Q3 2026 figure represents the lowest quarterly Operating Leases since fiscal Q3 2024.
- Year-over-year, Operating Leases has declined for three consecutive quarters, with growth averaging 44.8% over the last eight quarters.
- The fastest year-over-year change in Operating Leases over five years came in fiscal Q2 2022 (growth of 471.7%), and the weakest in fiscal Q4 2021 (a decline of 70.7%).
- Business Quant data shows ENTA's Operating Leases at $52.78 million (Q2 2026), $53.78 million (Q1 2026) and $54.76 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Enanta Pharmaceuticals | 367.20 Mn | -360.79 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.75 Mn |
| Mar 31, 2026 | 52.78 Mn |
| Dec 31, 2025 | 53.78 Mn |
| Sep 30, 2025 | 54.76 Mn |
| Jun 30, 2025 | 55.66 Mn |
| Mar 31, 2025 | 56.54 Mn |
| Dec 31, 2024 | 56.45 Mn |
| Sep 30, 2024 | 53.94 Mn |
| Jun 30, 2024 | 48.14 Mn |
| Mar 31, 2024 | 43.41 Mn |
| Dec 31, 2023 | 20.52 Mn |
| Sep 30, 2023 | 21.24 Mn |
| Jun 30, 2023 | 22.33 Mn |
| Mar 31, 2023 | 23.07 Mn |
| Dec 31, 2022 | 21.86 Mn |
| Sep 30, 2022 | 22.37 Mn |
| Jun 30, 2022 | 22.21 Mn |
| Mar 31, 2022 | 15.12 Mn |
| Dec 31, 2021 | 15.96 Mn |
| Sep 30, 2021 | 1.13 Mn |
Enanta Pharmaceuticals Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=ENTA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();